Products for Research Use Only
RegisterLogin

KF-20444

CAT: 0804-HY-105369Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-105369Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KF-20444 is an orally active ALK inhibitor with blood-brain barrier penetration. KF-20444 exhibits strong inhibitory activity against ALK fusion proteins (EML4-ALK) and ALK resistance mutations (including L1196M, G1202R, and F1174L) . KF-20444 effectively suppresses the phosphorylation of ALK in ALK-driven cancer cell lines, thereby inhibiting cancer cell proliferation and inducing apoptosis. KF-20444 demonstrates anti-tumor efficacy in mouse models bearing ALK-positive non-small cell lung cancer (NSCLC) or neuroblastoma. KF-20444 can be used for the study of ALK-driven malignancies[1].
CAS Number
154015-73-3
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK) ; Apoptosis
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(C1=C2CCCC3=C(C=CC(C4=C(F)C=CC=C4)=C3)C2=NC5=C1C=C(C=C5)F)O
Molecular Formula
C25H17F2NO2
Molecular Weight
401.40
References & Citations
[1]Kobayashi K, et al. Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis. Inflamm Res. 2001 Jan;50 (1) :24-31.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-U00231KF 13218
HY-117618KF-14124
HY-108159KF-15570
HY-105368KF 22678
HY-167655KF-19418
HY-170404-01KF-52
HY-105479KF 18259
HY-129641KF-392
HY-105505KF-17625
HY-170404A-01KF-52 enantiomer

Alternative Products

CatalogName
GTR19273713-01KF-20444
T70667-01KF 20274
T68726-01KF 4317
T25575-01KF 14124
T27727-01KF 17837S
2748/10KF 38789
GTR19241346-01KF-19418
MBS5813339KF 18259
MBS5775300KF 392
MBS5766925KF 13218

Popular Products